University of Melbourne partners with Illumina to genomics-based biomedical research and innovation

By Brisbane SEO

One of the world’s leading biotech companies has entered into a partnership with the University of Melbourne as it looks to enhance Melbourne’s reputation as a world class Biomedical Precinct.

In a statement released this week, Illumina announced that it has signed a Memorandum of Understanding (MoU) with the University to “increase genomics innovation and how it is translated and adopted into the healthcare system to improve patient outcomes.”

The partnership will be co-located at the Melbourne Biomedical Precinct in Parkville and is based on a four-pillared approach: international reach, clinical utility, data generation and talent development.

University of Melbourne Vice-Chancellor Professor Duncan Maskell said: “A partnership with a world-leading genomics company like Illumina will serve as a catalyst for innovation across Melbourne’s biomedical precinct. It strongly supports the University’s objective to collaborate with industry partners and develop programs that can make a real difference to people’s lives.”

Related stories:

Genomics-based biomedical research looks at the genetic information contained within the cells in the human body. Through the partnership, the two will look at genomics-based biomedical research and innovation in the detection and management of diseases such as cancer.

Illumina Vice President and General Manager for Asia Pacific and Japan Gretchen Weightman said: “Illumina’s Australia team is thrilled to be moving into the Biomedical Precinct later this year. Our hope is that co-location with the wider research community, and collaboration with the University of Melbourne, will enable a deeper engagement in collaborative research activities and clinical trials.

“The current momentum in genomics research is growing exponentially and we are inspired by the way it can stimulate job growth and economic activity to maximise the impact for Victoria, and more importantly fuel research with the potential to improve health outcomes for patients.”



Featured Articles

Hybrid live event shaping the future of Sustainability & ESG

Sustainability LIVE London returns for a two-day, multi-track conference programme featuring inspirational ESG speakers, debates and discussions

Nine must-attend sustainability events for business leaders

From London to Abu Dhabi, Singapore to San Diego, these sustainability-focused events are designed to help business leaders action their ESG goals

Daniel Weise of BCG on new supply chain and procurement book

Daniel Weise, global leader of Boston Consulting Group’s procurement business line, on the timely publication of his new book, Profit From The Source

Attract and retain talent with flexible working and benefits

Human Capital

Nurturing the next generation of women leaders in Africa

Leadership & Strategy

5 Mins With: Cybersecurity expert Ariel Parnes of Mitiga